Cupid Q2 FY27: Profit Soars 133%, Guidance Raised

Cupid Limited (NSE: CUPID), a healthcare and consumer wellness company, delivered a strong Q2 FY27 performance. Revenue from operations increased 122% YoY to ₹187.86 crore, while net profit rose 133% to ₹56.22 crore. Key Highlights Total income grew 132% YoY to ₹208.97 crore. EBITDA stood at ₹54.77 crore, with a 29% margin. H1 FY27 revenue from operations reached ₹342.58 crore, up 137%. H1 net profit increased 156% to ₹100.37 crore. Domestic business contributed 67% of H1 sales, indicating a growing consumer business. Management raised FY27 guidance to ₹880 crore+ revenue and ₹275 crore+ net profit. My View The numbers reflect strong growth across both domestic and international operations. What makes this result interesting is Cupid's increasing focus on its consumer healthcare and FMCG portfolio. Its partnerships with Style Baazar and V2 Retail could expand distribution significantly. The V2 Retail arrangement alone is expected to generate around ₹400 crore in revenue over the next 12 months. However, these are management estimates, not guaranteed outcomes. The company also needs to execute its expansion plans while maintaining margins. What I'm Watching Next The commissioning of the Palava manufacturing facility in Q3 FY27, revenue contribution from retail partnerships, and progress towards revised guidance will be important. The key question is whether Cupid can convert its expanding retail presence into sustainable earnings growth. Stance: Cautiously Positive – Strong execution so far, but future growth expectations are ambitious. Disclosure: I do not have any holding or position in the stock mentioned above. CUPID